PI3K/Akt/CREB activator 1 can be used in the study of vascular dementia (VaD); it promotes neuronal proliferation, induces differentiation of Neuro-2a cells into neuron-like morphology, and accelerates the establishment of axon-dendrite polarity in primary hippocampal neurons by upregulating brain-derived neurotrophic factor via the PI3K/Akt/CREB pathway.